D-0714-2018 Class III Terminated
FDA drug recall D-0714-2018 was initiated by Mckesson Packaging Services on Apr 23, 2018 and is designated Class III. Reason for recall: Failed Dissolution Specifications. High dissolution results were obtained during stability testing. The recall status is terminated (terminated Oct 13, 2020). Affected quantity: 4266 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- May 2, 2018
- Initiation Date
- Apr 23, 2018
- Termination Date
- Oct 13, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4266 cartons
Product description
Diltiazem HCl Extended-Release Capsules, USP 120 mg, 100-count bottles, Rx only, Mfg. By: Par Pharmaceutical One Ram Ridge Rd Chestnut Ridge, NY 10977. NDC: 63739-014-10
Reason for recall
Failed Dissolution Specifications. High dissolution results were obtained during stability testing.
Distribution pattern
Nationwide with the US
Code information
Lot #: 0115086, Exp. 12/2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0714-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026